Searched for
RITUXIMAB
Can Covid vaccines work on compromised immune systems?Immunocompromised people aren't a uniform group, and so may respond to vaccines differently.11 Aug, 2021, 06.27 PM IST- Expect to launch 25 products in US this fiscal: Dr Reddy'sDr Reddy's Laboratories expects to launch 25 products in the US market in the current financial year, according to a top company official. ...28 Jun, 2020, 02.33 PM IST
- Roche Pharma India expands partnership with Cipla for key oncology medicinesRoche Pharma India has signed a "distribution agreement with Cipla to expand the scope of the partnership to include, marketing and distrib...18 Jun, 2020, 11.45 AM IST
- Desi pharma companies top in biosimilars globallyBiosimilars are approved versions of biopharmaceuticals — complex medicines manufactured using live organisms, as against conventional drug...29 Oct, 2018, 10.31 AM IST
- Roche, Emcure may end pact to make 2 blockbuster drugsEmcure is still the distributor for those two drugs in India. Roche had handed out the manufacturing and marketing of trastuzumab and ritux...24 Jul, 2017, 11.55 PM IST
- Reliance Life gains global rights for copies of InfliximabFor Infliximab, Reliance Life Sciences had completed process development, manufacturing, clinical trials in India and obtained marketing ap...26 Jul, 2016, 04.30 AM IST
- Neutral Dr Reddy's Laboratories, target Rs 3400: UBSThe R&D spend is likely to increase led by proprietary products. In-license deals are likely to aid India business05 Jul, 2016, 01.31 PM IST
- Reliance Lifesciences launches world's first biosimilar used to treat advanced cancersIn 2014, Reliance had entered into a similar arrangement with Torrent Pharma to sell copies of three drugs -- rituximab, adalimumab and cet...10 Jun, 2016, 03.05 AM IST
- Hetero launches biosimilar Rituximab in IndiaHetero has launched biosimilar Rituximab in India used for treatment of certain types of cancers and rheumatoid arthritis under the brand n...03 Aug, 2015, 06.31 PM IST
- Hetero launches biosimilar Rituximab in IndiaHyderabad based Hetero pharma has launched biosimilar drug Rituximab under the brand name of MABALL, used in the treatment of blood cancer.03 Aug, 2015, 04.56 PM IST
- Claris Lifesciences gets USFDA drug approvalClaris Lifesciences Ltd, a parenteral drug company has received drug approval from US drug authorities for hypertension and angina treatmen...01 May, 2013, 04.22 PM IST
- Intas Pharmaceutical launches low cost drug 'Mabtas' for cancer treatmentIntas Pharmaceutical today said it has launched 'Mabtas' a new low cost drug for treating cancer in India.30 Apr, 2013, 06.54 PM IST
- Swiss-based Roche to produce two cancer drugs locally with Emcure Pharma: GovtRoche has entered into an agreement for a transfer technology project with Emcure for local manufacturing of its two patented cancer drugs.01 Mar, 2013, 04.10 PM IST
- Dr Reddy's Laboratories bets big on biosimilars, eyes regulated marketsHyderabad-based Dr Reddy's Laboratories is betting big on the biosimilars segment and expects to enter developed markets soon.18 Jul, 2012, 08.45 PM IST
- Natco Pharmaceuticals inks pact with Swiss firm Chemo Sa Lugano for purchase of drug ingredientsNatco Pharmaceuticals said it has entered into an agreement with Mabxience to purchase four ingredients that will be used in finished drugs.18 Oct, 2011, 04.08 PM IST
- Kidney transplants cross blood group barrierIt was love that prompted Nashik resident Meera Dhikale to donate one of her kidneys to her husband Fakira, but in the process the couple m...15 Sep, 2010, 01.52 AM IST
- Roche gets nod for Mabthera for arthritisRoche has received approval for its drug Mabthera (rituximab) in India for the treatment of rheumatoid arthritis.21 Nov, 2006, 02.39 AM IST
Load More
